Rating scales in bipolar disorder

Current Opinion in Psychiatry

Volumn 22, Issue 1, 2009, Pages 42-49

  Picardi, Angelo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Bipolar disorder; Early diagnosis; Outcome assessment; Screening

Indexed keywords

ACCURACY; ALGORITHM; BECH-RAFAELSEN MELANCHOLIA SCALE; BIPOLAR DISORDER; DEPRESSION; HUMAN; MANIA; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEGATIVE SYNDROME; QUESTIONNAIRE; RATING SCALE; REVIEW; SCORING SYSTEM; SCREENING; SELF EVALUATION; SELF REPORT; SENSITIVITY ANALYSIS; YOUNG MANIA RATING SCALE;

BIPOLAR DISORDER; EARLY DIAGNOSIS; HUMANS; MASS SCREENING; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 57749184820     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328315a4d2     Document Type: Review

References (47)

1. Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 2004; 161:2163-2177.
2. Demyttenaere K, De Fruyt J. Getting what you ask for: on the selectivity of depression rating scales. Psychother Psychosom 2003; 72:61-70.
3. Berk M, Ng F, Wang WV, et al. The empirical redefinition of the psychometric criteria for remission in bipolar disorder. J Affect Disord 2008; 106:153-158. This analysis of data from four clinical trials found that a cut-off score of less than five on the MADRS and less than four on the YMRS corresponded with an objective global clinical measure of remission in patients with bipolar disorder. Though lower than conventional cut-off scores, these empirically based cut-off points may be more clinically meaningful.
4. Bech P. The Bech-Rafaelsen Melancholia Scale (MES) in clinical trials of therapies in depressive disorders: a 20-year review of its use as outcome measure. Acta Psychiatr Scand 2002; 106:252-264.
5. Vieta E, Bobes J, Ballesteros J, et al. Validity and reliability of the Spanish versions of the Bech-Rafaelsen's mania and melancholia scales for bipolar disorders. Acta Psychiatrica Scandinavica 2008; 117:207-215. This study of the classical psychometric properties of the MES and MAS in over 200 patients with bipolar disorder further corroborated the validity of these instruments also in non-English-speaking nations.
6. Henry C, M'Bailara K, Poinsot R, et al. Evidence for two types of bipolar depression using a dimensional approach. Psychother Psychosom 2007; 76:325-331. This study used a new 20-item self-report visual analogue scale, the Multidimensional Assessment of Thymic State (MAThyS), assessing emotional reactivity, cognitive speed, psychomotor function, motivation, and sensory perception. Its findings lend further support to the notion that bipolar depressive states are not homogeneous, and suggest that an 'emotional reactivity' dimension can be useful to discriminate between different forms of bipolar depression.
7. Henry C, M'Bailara K, Desage A, et al. Towards a reconceptualization of mixed states, based on an emotional-reactivity dimensional model. J Affect Disord 2007; 101:35-41. This cluster analytic study suggested that a dimensional approach based on the construct of emotional reactivity as measured by the MAThyS can be useful to identify patients with depressive mixed states.
8. Berk M, Malhi GS, Cahill C, et al. The Bipolar Depression Rating Scale (BDRS): its development, validation and utility. Bipolar Disorders 2007; 9:571-579. This paper describes the development and validation of an observer-rated scale for the assessment of depressive symptoms in patients with bipolar disorder that was specifically designed to take into account the peculiar characteristics of depression in these patients.
9. Bowden CL, Singh V, Thompson P, et al. Development of the Bipolar Inventory of Symptoms Scale. Acta Psychiatr Scand 2007; 116:189-194. The authors report about the development and the preliminary validation of a clinician-rated scale designed to assess the full spectrum of bipolar symptomatology.
10. Suppes T, Rush AJ, Dennehy EB, et al. Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. J Clin Psychiatry 2003; 64:370-382.
11. Sachs GS. Strategies for improving treatment of bipolar disorder: integration of measurement and management. Acta Psychiatr Scand 2004; 110 (Suppl 422):7-17.
12. Parker G, Tully L, Olley A, Barnes C. The validity and utility of patients daily ratings of mood and impairment in clinical trials of bipolar disorder. Acta Psychiatr Scand 2007; 115:366-371. This study on a small sample of patients with type II bipolar disorder participating in a clinical trial reported encouraging preliminary validity data for the Patient Mood Chart (PMC), a new self-rated measure of daily mood and functional impairment.
13. Hantouche EG, Allilaire JP, Bourgeois ML, et al. The feasibility of self-assessment of dysphoric mania in the French national EPIMAN study. J Affect Disord 2001; 67:97-103.
14. Bech P. The Bech-Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: a 20-year review of its use as an outcome measure. CNS Drugs 2002; 16:47-63.
15. Houston JP, Lipkovich IA, AhI J, et al. Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium. J Psychiatr Res 2007; 41:616-621. The findings of this study suggest that frequent monitoring of symptoms and early recognition of symptom exacerbation, particularly increased motor activity-energy, may help averting relapse in patients who have recently recovered from a manic episode.
16. Patel NC, Patrick DM, Youngstrom EA, et al. Response and remission in adolescent mania: signal detection analyses of the young mania rating scale. J Am Acad Child Adolesc Psychiatry 2007; 46:628-635. Signal detection analyses of data from treatment studies of adolescents with acute mania were performed to evaluate the efficiency of selected cut-offs associated with response and remission. A reduction of at least 55% in YMRS scores was the optimal cut-off defining response, while an YMRS score of 12 or lower was the optimal cut-off defining remission.
17. Young RC, Kiosses D, Heo M, et al. Age and ratings of manic psychopathology. Bipolar Disord 2007; 9:301-304. Overall, the findings of this study did not corroborate the notion that manic symptomatology changes with age. In 149 manic patients aged 18 to 89 years, age was not associated either with YMRS total score or with YMRS item scores, except for scores on the sexual interest and speech rate and amount items that were modestly correlated with age.
18. Azorin JM, Kaladjian A, Akiskal HS, et al. Validation of a severity threshold for the Mania Rating Scale: a receiver-operating characteristic analysis. Psychopathology 2007; 40:453-460. In this study on a large national clinical sample of hospitalized manic patients receiver operating characteristic (ROC) analysis was used to determine an empirically based cut-off score for severe mania on the Mania Rating Scale.
19. Jaeger J, Berns S, Loftus S, et al. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord 2007; 9:93-102. This study highlighted the predictive value of neurocognitive deficits, independent of residual mania as measured by the CARS-M and depression as measured by the HDRS, for long-term functional recovery following hospitalization for an acute affective episode.
20. Yen CF, Chen CS, Yen JY, Ko CH. The predictive effect of insight on adverse clinical outcomes in bipolar I disorder: a two-year prospective study. J Affect Disord 2008; 108:121-127. In this study, poorer insight into treatment was found to be an independent predictor of adverse clinical outcomes such as psychiatric hospitalization, emergency room visits, and violent or suicidal behaviour.
21. Dias VV, Brissos S, Carita AI. Clinical and neurocognitive correlates of insight in patients with bipolar I disorder in remission. Acta Psychiat Scand 2008; 117:28-34. This study corroborated previous reports of an association between impaired insight and cognitive dysfunction in patients with bipolar disorder.
22. Varga M, Magnusson A, Flekkoy K, et al. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter? Comprehensive Psychiatry 2007; 48:583-591. This study found that poorer insight is associated with increased severity of affective symptoms and greater impairment in working memory among patients with bipolar disorder.
23. Altman E, Hedeker D, Peterson JL, Davis JM. A comparative evaluation of three self-rating scales for acute mania. Biol Psychiatry 2001; 50:468-471.
24. Cassano GB, Mula M, Rucci P, et al. The structure of lifetime manic-hypomanic spectrum. J Affect Disord 2008 [Epub ahead of print] In this interesting study, an item response theory-based factor analytic approach was used to examine the lifetime structure of mania/hypomania. The analysis was performed on 68 items of the MOODS-SR that explore energy, mood and cognitive features associated with mania/hypomania.
25. Jonsdottir H, Engh JA, Friis S, et al. Measurement of insight in patients with bipolar disorder: are self-rated scales developed for patients with schizophrenia applicable? J Nerv Ment Dis 2008; 196:333-335. This study, in which the psychometric properties of the Birchwood Insight Scale were found to be poorer in bipolar disorder than in schizophrenia, highlights the need for caution when using self-rated instruments validated in patients with different diagnoses.
26. Picardi A, Battisti F, de Girolamo G, et al. Symptom structure of acute mania: a factor study of the 24-item Brief Psychiatric Rating Scale in a national sample of patients hospitalized for a manic episode. J Affect Disord 2008; 108:183-189. Consistently with most previous studies, this study identified a mania factor, a positive symptoms factor, and a dysphoria factor. Also, the identification of a disorganization factor in a sample including only manic patients was a new finding that needs confirmation and may have clinical implications.
27. Lindenmayer JP, Bossie CA, Kujawa M, et al. Dimensions of psychosis in patients with bipolar mania as measured by the Positive and Negative Syndrome Scale. Psychopathology 2008; 41:264-270. This study, performed on a large sample of manic patients, showed interesting similarities in psychotic symptom domains in patients with mania and schizophrenia. The similarities were most notable in the subsample of manic patients with psychotic features.
28. Canuso CM, Bossie CA, Zhu Y, et al. Psychotic symptoms in patients with bipolar mania. J Affect Disord 2008 [Epub ahead of print]. In this study, the PANSS was used together with the YMRS to identify psychotic symptoms in a large sample of patients with acute mania. The findings corroborated previous reports of a high prevalence of psychosis in manic patients.
29. Bertschy G, Gervasoni N, Favre S, et al. Phenomenology of mixed states: a principal component analysis study. Bipolar Disord 2007; 9:907-912. This study pointed to the relevance of a dysphoria component, independent from depressive and manic symptoms, in patients with mixed states.
30. Salvatore P, Khalsa HM, Hennen J, et al. Psychopathology factors in first-episode affective and nonaffective psychotic disorders. J Psychiatr Res 2007; 41:724-736. In this study, the AMDP system and the BSABS were used to retrospectively characterize a broad range of psychopathological features in a large group of individuals hospitalized for first-lifetime episode of primary psychotic illnesses with at least 2 years of follow-up data available. This dimensional approach to diagnosis based on symptom profiles over time was effective in identifying and subtyping affective psychotic disorders early in their clinical evolution, while nonaffective and schizoaffective conditions appeared to be more heterogeneous and unstable.
31. Azorin JM, Akiskal H, Akiskal K, et al. Is psychosis in DSM-IV mania due to severity? The relevance of selected demographic and comorbid social-phobic features. Acta Psychiatr Scand 2007; 115:29-34. In this study investigating whether factors other than episode severity contribute to psychosis in mania, the MRS was supplemented by the SAPS in the assessment of the severity of the current episode. The results suggested an association between manic psychosis and social isolation, independently from episode severity.
32. Mantere O, Suominen K, Arvilommi P, et al. Clinical predictors of unrecognized bipolar I and II disorders. Bipolar Disord 2008; 10:238-244. In this study, the MDQ was used to screen psychiatric inpatients and outpatients for bipolar disorder, and suspected cases were diagnosed with the SCID-I. Consistently with previous studies, it was found that many patients with bipolar disorder, especially type II, go unrecognized even in psychiatric settings. A comparison between correctly diagnosed patients and unrecognized patients suggested that an important factor in misdiagnosis might be excessive reliance on typical and cross-sectional presentations of bipolar disorder.
33. Arvilommi P, Suominen KS, Mantere OK, et al. Adequacy of treatment received by diagnosed and undiagnosed patients with bipolar I and II disorders. J Clin Psychiatry 2007; 68:102-110. In this study, carried out on a large sample of psychiatric patients, the MDQ was used to screen for bipolar disorder and the SCID-I was used to corroborate the diagnosis. A correct diagnosis was by far the most important prerequisite for adequate treatment of bipolar disorder, and outpatients received adequate treatment markedly less often than inpatients. These findings suggest that adequacy of treatment of bipolar depression is a major concern in outpatient settings.
34. Hirschfeld RM. Screening for bipolar disorder. Am J Manag Care 2007; 13 (7 Suppl):S164-169. This short but informative review highlights the need to take steps to improve recognition of bipolar disorder in order to provide adequate treatment.
35. Sanchez-Moreno J, Villagran JM, Gutierrez JR, et al. Adaptation and validation of the Spanish version of the Mood Disorder Questionnaire for the detection of bipolar disorder. Bipolar Disord 2008; 10:400-412. This study corroborated the validity and the reliability (not only homogeneity but also stability over time) of a non-English version of the MDQ.
36. de Dios C, Ezquiaga E, Garcia A, et al. Usefulness of the Spanish version of the mood disorder questionnaire for screening bipolar disorder in routine clinical practice in outpatients with major depression. Clin Pract Epidemiol Ment Health 2008; 4:14. This small study corroborated the usefulness of the MDQ in the routine clinical assessment of apparently unipolar depression.
37. Graves RE, Alim TN, Aigbogun N, et al. Diagnosing bipolar disorder in trauma exposed primary care patients. Bipolar Disord 2007; 9:318-323. This study highlighed the limitations of self-completed psychiatric screeners in some patient populations. The MDQ was tested against the SCID and was found to have low positive predictive value and low specificity in a predominanty African - American group of trauma-exposed patients attending primary care.
38. Twiss J, Jones S, Anderson I. Validation of the Mood Disorder Questionnaire for screening for bipolar disorder in a UK sample. J Affect Disord 2008 [Epub ahead of print] In this study the optimal sensitivity and specificity cut-off thresholds for the MDQ were investigated in patients with mood disorders attending a tertiary clinic. The findings suggest that, at least in psychiatric settings, sensitivity is fairly high and may be further improved by dropping the supplementary questions.
39. Meyer TD, Hammelstein P, Nilsson LG, et al. The Hypomania Checklist (HCL-32): its factorial structure and association to indices of impairment in German and Swedish nonclinical samples. Comprehensive Psychiatry 2007; 48:79-87. This study showed that the symptom structure of hypomania as measured with the HCL-32 is similar in clinical and nonclinical samples.
40. Wu YS, Angst J, Ou CS, et al. Validation of the Chinese version of the hypomania checklist (HCL-32) as an instrument for detecting hypo(mania) in patients with mood disorders. J Affect Disord 2008; 106:133-143.
41. Vieta E, Sanchez-Moreno J, Bulbena A, et al. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32). J Affect Disord 2007; 101:43-55.
42. Parker G, Fletcher K, Barrett M, et al. Screening for bipolar disorder: the utility and comparative properties of the MSS and MDQ measures. J Affect Disord 2008; 109:83-89. This study provided independent validity data for the MSS and its shorter version. They were compared with the MDQ in their ability to distinguish bipolar disorder from unipolar depression in patients attending a depression clinic and they displayed similar performances.
43. Phelps JR, Ghaemi SN. Improving the diagnosis of bipolar disorder: predictive value of screening tests. J Affect Disord 2006; 92:141-148.
44. Correll CU, Penzner JB, Lencz T, et al. Early identification and high-risk strategies for bipolar disorder. Bipolar Disord 2007; 9:324-338. This paper reviews different identification strategies for individuals at risk for bipolar disorder and suggests that clinical high-risk approaches aimed at the identification of individuals in subsyndromal or attenuated 'prodromal' stages of bipolar disorder hold promise and have great potential to inform early identification and intervention programmes.
45. Hauser M, Pfennig A, Ozgurdal S, et al. Early recognition of bipolar disorder. Eur Psychiatry 2007; 22:92-98. This paper reviews the challenge posed by early recognition of bipolar disorder and provides interesting suggestions for the development of an early recognition scale and for the assessment of its predictive validity.
46. Correll CU, Penzner JB, Frederickson AM, et al. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Schizophr Bull 2007; 33:703-714. In this study, a newly developed assessment instrument, the Bipolar Prodrome Symptom Scale-Retrospective was used to collect information regarding the mania prodrome. The finding of a lengthy and symptomatic prodromal phase suggests that clinical high-risk programmes for bipolar disorder may be feasible.
47. Nierenberg AA, Ostacher MJ, Borrelli DJ, et al. The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry. J Clin Psychiatry 2006; 67 (Suppl 11):3-7.